Regulated information

Matthieu Frechin named Managing Director of Vétoquinol

December 14, 2009 (Lure, France) – The Board of Directors of Vétoquinol, at its December 10
meeting, has named Matthieu Frechin Managing Director of the Vétoquinol Group, replacing
Etienne Frechin. He will be seconded by Dominique Henryon, Deputy General Manager.
Etienne Frechin will give up all operating functions but will continue to serve as Chairman of
Vétoquinol’s Board of Directors.

Strong growth in Revenues in the 3rd quarter

Vétoquinol recorded strong growth in the 3rd quarter of 2009, despite an unfavourable exchange rate effect. The strength in sales was due to a combination of the contribution of acquisitions in Italy and India and sustained organic growth.

Vétoquinol posts resilient results in the first half of 2009 and continues to pursue its international growth

The Board of Directors of Vétoquinol, meeting on August 27, reviewed the group’s business and approved the group’s interim 2009 financial statements.

Vétoquinol completes the acquisition of Wockhardt Animal Health in India

August 20, 2009 (Lure, France) – Vétoquinol today announced the completion of its acquisition of the animal health business division of Wockhardt Limited, based in Mumbaï, India. This acquisition was the subject of an agreement signed with the Wockhardt Limited group on June 26.

Growth in Revenues in the first half of 2009

Vétoquinol’s revenues in the first half of 2009 totalled EUR 119.9 million, an increase of 2.7% compared to the first half of the preceding year.

Vétoquinol enters the indian market

June 29, 2009 (Lure, France) – Vétoquinol today announced the signing of an agreement for the acquisition of the Animal Health Division of Wockhardt Limited, based in Mumbaï, India.

Modalité de mise à disposition ou consultation du rapport annuel financier 2008 (french)

Le Rapport annuel financier 2008, peut être consulté ou téléchargé
sur le site Internet de Vétoquinol.

2008 financial report

Laboratoire pharmaceutique vétérinaire familial et indépendant, Vétoquinol se consacre exclusivement à la santé animale. Son activité est volontairement équilibrée entre animaux de rente et animaux de compagnie.
<br>
Historiquement implanté sur le marché français, le groupe réalise désormais 78% de son chiffre d'affaires consolidé à l'international (234,4 millions d'euros en 2008). Les 1400 collaborateurs du Groupe se répartissent entre la Recherche & Développement, la production et la commercilisation.
<br>
Aujourd'hui, la PME française -11e acteur mondial en santé animale (hors aliments)- produit et distribue 700 médicaments et produits non médicamenteux dans près de 100 pays (Europe, Amérique du Nord et Asie). Elle s'appuie sur ses filiales dans 22 pays et sur un réseau de 140 partenaires distributeurs.

2009 Revenue improvement in trends in the first quarter

Vétoquinol’s revenue for the first quarter of 2009 reached €57.1 M, an increase of 4.4% over the first quarter of 2008.

2008 annual earnings

The Vétoquinol Board of Directors, meeting on March 20, 2009, reviewed the group’s business and approved the group’s 2008 financial statements.